First in new biologics class to treat psoriasis

psoriasis treatment cosentyx
The first in a new class of biologic medicine that acts to interrupt the inflammatory cycle and help clear the skin of patients with moderate-to-severe psoriasis has been added to the PBS from September 1, 2015. The PBS listing of Cosentyx – the first interleukin-17A inhibitor – for patients with severe chronic plaque psoriasis refractory

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous CM exports to Asia more than double over past year
Next Women get bowel cancer too: new campaign